GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Total Long-Term Liabilities

HLB Science (XKRX:343090) Total Long-Term Liabilities : ₩0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. HLB Science's Total Long-Term Liabilities for the quarter that ended in . 20 was ₩0.00 Mil.


HLB Science Total Long-Term Liabilities Historical Data

The historical data trend for HLB Science's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Total Long-Term Liabilities Chart

HLB Science Annual Data
Trend Dec22 Dec23
Total Long-Term Liabilities
110.39 1,817.19

HLB Science Quarterly Data
Total Long-Term Liabilities

HLB Science Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


HLB Science Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of HLB Science's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines